Synthetic pineal tetrapeptide (research)
Epithalon
Ala-Glu-Asp-Gly tetrapeptide studied in ageing models for telomerase and pineal signalling hypotheses.
Primary Mechanism of Action
Clinical / Scientific
Epithalon (epitalon) is a synthetic tetrapeptide from pineal peptide research. Reports of telomerase activation and circadian/pineal effects are experimental. It is not an approved longevity medicine.
Pathway Targets
Telomerase-related signalling (models)
Scientific explanation
Experimental ageing-biology readouts.
Pathway Convergence
Clinical / Scientific
Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.
Receptor to physiology
Target to downstream effect: Telomerase-related signalling (models)
Mechanistically Relevant Repurposed & Adjunctive Applications
Research peptide context
PreclinicalMechanistic rationale
Catalogued as a research peptide. Mechanistic statements below describe known or pathway biology and do not establish a licensed therapeutic indication.
Mechanistic Application Matrix
| Biological Target | Mechanism | Potential Relevance | Evidence Level |
|---|---|---|---|
| Telomerase / pineal signalling | Experimental modulation | Ageing models | Preclinical |
In Plain Language
Epithalon is a four-amino-acid pineal-inspired peptide from ageing research. Telomere stories remain experimental.
Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.